High rates of Ki-ras point mutation in both intra- and extra-hepatic cholangiocarcinomas
- PMID: 7830335
High rates of Ki-ras point mutation in both intra- and extra-hepatic cholangiocarcinomas
Abstract
The presence of the Ki-ras gene mutations in 14 cases of intrahepatic cholangiocarcinoma (IHC) and nine cases of extrahepatic cholangiocarcinoma (EHC) were investigated by polymerase chain reaction-single strand conformation polymorphism analysis. To obtain enriched tumor cell DNA, the microdissection method was used on formalin-fixed paraffin-embedded tissue sections. Point mutations at codon 12 of the Ki-ras gene were detected in seven (50%) of the 14 cases of IHC and six (67%) of the nine EHC cases. In all but one of the ras gene mutation cases, G to A transitions in the second position of codon 12 were detected, the exception being a G to T transition in the same position in one IHC. No point mutations were detected at codon 13 or 61 in either IHC or EHC. Furthermore, there was no demonstrable correlation between Ki-ras mutation and patient age, tumor Stage, histological findings or prognosis. The present results demonstrated a higher participation of Ki-ras gene mutations in EHC than found in previous studies, and provided a confirmation and extension of the results earlier reported by Tada et al. and Tsuda et al. for IHC.
Similar articles
-
The incidence of K-ras codon 12 mutations in cholangiocarcinoma detected by polymerase chain reaction technique.J Med Assoc Thai. 1998 May;81(5):316-23. J Med Assoc Thai. 1998. PMID: 9623030 Clinical Trial.
-
K-ras oncogene and p53 gene mutations in cholangiocarcinoma from Thai patients.Southeast Asian J Trop Med Public Health. 1998 Mar;29(1):71-5. Southeast Asian J Trop Med Public Health. 1998. PMID: 9740272
-
Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma.Lab Invest. 1999 Apr;79(4):477-83. Lab Invest. 1999. PMID: 10212000
-
Point mutations of the c-Ki-ras gene in carcinoma and atypical epithelium associated with congenital biliary dilation.Am J Gastroenterol. 1996 Jun;91(6):1211-4. Am J Gastroenterol. 1996. PMID: 8651173
-
K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.Am J Pathol. 1993 Aug;143(2):545-54. Am J Pathol. 1993. PMID: 8342602 Free PMC article. Review.
Cited by
-
Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma.PLoS Genet. 2014 Feb 13;10(2):e1004135. doi: 10.1371/journal.pgen.1004135. eCollection 2014 Feb. PLoS Genet. 2014. PMID: 24550739 Free PMC article.
-
Increased telomerase activities in human pancreatic duct adenocarcinomas.Jpn J Cancer Res. 1997 Oct;88(10):971-6. doi: 10.1111/j.1349-7006.1997.tb00317.x. Jpn J Cancer Res. 1997. PMID: 9414659 Free PMC article.
-
Epidemiology of cholangiocarcinoma: an update focusing on risk factors.Cancer Sci. 2010 Mar;101(3):579-85. doi: 10.1111/j.1349-7006.2009.01458.x. Epub 2009 Dec 4. Cancer Sci. 2010. PMID: 20085587 Free PMC article. Review.
-
Ki-ras point mutations and proliferation activity in biliary tract carcinomas.Br J Cancer. 1996 Sep;74(6):930-5. doi: 10.1038/bjc.1996.459. Br J Cancer. 1996. PMID: 8826860 Free PMC article.
-
Genetic alterations in Japanese extrahepatic biliary tract cancer.Oncol Lett. 2017 Jul;14(1):877-884. doi: 10.3892/ol.2017.6224. Epub 2017 May 22. Oncol Lett. 2017. PMID: 28693246 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical